Delacroix Elected To NCI Steering Committee
NEW ORLEANS – Scott Delacroix, Jr., MD, Director of Urologic Oncology at LSU Health New Orleans School of Medicine, has been elected as the new community oncology representative to the Genitourinary Steering Committee, one of the Scientific Steering Committees of the National Cancer Institute’s Coordinating Center for Clinical Trials.
Dr. Delacroix is an assistant professor of urology and serves as Clinical Trails Site Leader at LSU Health New Orleans Stanley S. Scott Cancer Center’s Minority/ Underserved NCI Community Oncology Research Program, where he also leads the Genitourinary Multidisciplinary Cancer Care Team. He will serve a minimum of a three-year term on the steering committee.
According to the National Cancer Institute, Scientific Steering Committees (SSCs) are composed of leading cancer experts and advocates from outside the Institute as well as NCI senior investigators who meet regularly to:
• Increase the transparency and openness of the trial design and prioritization process;
• Enhance patient advocate and community oncologist involvement in clinical trial design and prioritization;
• Evaluate clinical trial concepts and set disease-specific strategic priorities;
• Convene Clinical Trial Planning Meetings to identify critical questions, unmet needs, and prioritize key strategies.
Dr. Delacroix, a board-certified urologist, graduated from LSU Health New Orleans School of Medicine and completed a fellowship in Urologic Oncology at the University of Texas MD Anderson Cancer Center, where he also served as a clinical specialist of urology.
